| Product Code: ETC7734137 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Cell And Gene Therapy Clinical Trial Services Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Cell And Gene Therapy Clinical Trial Services Market - Industry Life Cycle |
3.4 Japan Cell And Gene Therapy Clinical Trial Services Market - Porter's Five Forces |
3.5 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.7 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapeutic Areas, 2021 & 2031F |
3.8 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 Japan Cell And Gene Therapy Clinical Trial Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development of cell and gene therapies in Japan |
4.2.2 Favorable regulatory environment supporting the growth of clinical trials in the field |
4.2.3 Growing prevalence of genetic disorders and chronic diseases driving the demand for advanced therapies |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy clinical trials |
4.3.2 Stringent regulatory requirements for approval and conducting trials |
4.3.3 Limited availability of skilled professionals and infrastructure for conducting clinical trials |
5 Japan Cell And Gene Therapy Clinical Trial Services Market Trends |
6 Japan Cell And Gene Therapy Clinical Trial Services Market, By Types |
6.1 Japan Cell And Gene Therapy Clinical Trial Services Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Site Identification, 2021- 2031F |
6.1.4 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Patient Recruitment, 2021- 2031F |
6.1.5 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Laboratory Services, 2021- 2031F |
6.1.6 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Regulatory Services, 2021- 2031F |
6.1.7 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Supply and Logistic Services, 2021- 2031F |
6.1.8 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Cell And Gene Therapy Clinical Trial Services Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.3 Japan Cell And Gene Therapy Clinical Trial Services Market, By Therapeutic Areas |
6.3.1 Overview and Analysis |
6.3.2 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3.4 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.5 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.6 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Musculoskeletal, 2021- 2031F |
6.3.7 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Cell And Gene Therapy Clinical Trial Services Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.4.3 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Gene-modified Cell Therapy, 2021- 2031F |
6.4.4 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.4.5 Japan Cell And Gene Therapy Clinical Trial Services Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Cell And Gene Therapy Clinical Trial Services Market Import-Export Trade Statistics |
7.1 Japan Cell And Gene Therapy Clinical Trial Services Market Export to Major Countries |
7.2 Japan Cell And Gene Therapy Clinical Trial Services Market Imports from Major Countries |
8 Japan Cell And Gene Therapy Clinical Trial Services Market Key Performance Indicators |
8.1 Patient recruitment and retention rates in cell and gene therapy clinical trials |
8.2 Time taken for regulatory approval of clinical trials |
8.3 Adoption rate of innovative technologies in trial design and execution |
9 Japan Cell And Gene Therapy Clinical Trial Services Market - Opportunity Assessment |
9.1 Japan Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Japan Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.3 Japan Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapeutic Areas, 2021 & 2031F |
9.4 Japan Cell And Gene Therapy Clinical Trial Services Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10 Japan Cell And Gene Therapy Clinical Trial Services Market - Competitive Landscape |
10.1 Japan Cell And Gene Therapy Clinical Trial Services Market Revenue Share, By Companies, 2024 |
10.2 Japan Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here